1832 Asset Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-59
Closed -$1.22K 833
2024
Q2
$1.22K Hold
59
﹤0.01% 851
2024
Q1
$1.11K Hold
59
﹤0.01% 858
2023
Q4
$851 Sell
59
-25
-30% -$340 ﹤0.01% 801
2023
Q3
$1.46K Buy
84
+15
+22% +$313 ﹤0.01% 820
2023
Q2
$1.44K Buy
69
+10
+17% +$217 ﹤0.01% 826
2023
Q1
$1.39K Hold
59
﹤0.01% 869
2022
Q4
$1.65K Sell
59
-6
-9% -$153 ﹤0.01% 868
2022
Q3
$2K Sell
65
-4
-6% -$121 ﹤0.01% 861
2022
Q2
$2K Sell
69
-11
-14% -$385 ﹤0.01% 853
2022
Q1
$3K Buy
+80
New +$2.74K ﹤0.01% 910

Other funds holding OGN

1832 Asset Management's OGN Position: Q3 2024 in Review

1832 Asset Management sold out of Organon & Co (OGN) in Q3 2024, closing a stake of 59 shares — an estimated $1.22K sold.

1832 Asset Management first reported a position in OGN in Q1 2022 and held it in 10 quarters. The position peaked at $3K in Q1 2022. 724 funds tracked by Wall St. Rank hold OGN as of Q3 2024.

  • 1832 Asset Management reported no remaining Organon & Co position as of Q3 2024 after selling out during the quarter.
  • 1832 Asset Management sold 59 Organon & Co shares in Q3 2024, an estimated $1.22K.
  • 1832 Asset Management first reported a position in Organon & Co in Q1 2022 and held it in 10 quarters.
  • 1832 Asset Management's Organon & Co position peaked at $3K in Q1 2022.
  • 724 funds tracked by Wall St. Rank held Organon & Co as of Q3 2024.

Based on 1832 Asset Management's 13F filing for Q3 2024, filed 13 Nov 2024.